Literature DB >> 12541002

The prevalence of autism spectrum disorders. Recent evidence and future challenges.

Tony Charman1.   

Abstract

BACKGROUND: Until recently best estimate prevalence rates for autism spectrum disorders (ASD) were 0.5/1,000 for autism and 2.0/1,000 for the broader spectrum. Three recent studies have suggested a significantly higher prevalence rate for ASD of 6.0/1,000 (mean 95 % CI = 4.8-8.0).
METHOD: Possible determinants of the apparent increase in the prevalence of ASD are outlined. Methodological aspects of the three recent studies are examined.
FINDINGS: Increased recognition, the broadening of the diagnostic concept over time and methodological differences across studies may account for most or all of the apparent increase in prevalence, although this cannot be quantified.
CONCLUSIONS: Findings from ongoing studies should help confirm or disconfirm the putative rate of 6.0/1,000 for all ASD. The possibility that autism has been over-diagnosed in recent studies needs to be ruled out. Notwithstanding these outstanding questions, it appears likely that the current true prevalence of ASD is considerably greater than previously recognised. This has significant implications for our scientific understanding of ASD and for families and services. Future directions for epidemiological research are outlined.

Entities:  

Mesh:

Year:  2002        PMID: 12541002     DOI: 10.1007/s00787-002-0297-8

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  23 in total

1.  Sex differences in the evaluation and diagnosis of autism spectrum disorders among children.

Authors:  Ellen Giarelli; Lisa D Wiggins; Catherine E Rice; Susan E Levy; Russell S Kirby; Jennifer Pinto-Martin; David Mandell
Journal:  Disabil Health J       Date:  2009-11-08       Impact factor: 2.554

2.  Contextual Factors Predict Patterns of Change in Functioning over 10 Years Among Adolescents and Adults with Autism Spectrum Disorders.

Authors:  Ashley C Woodman; Leann E Smith; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2016-01

Review 3.  Consequences of prenatal toxin exposure for mental health in children and adolescents: a systematic review.

Authors:  Justin H G Williams; Louise Ross
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-01-02       Impact factor: 4.785

4.  Trends in autism prevalence: diagnostic substitution revisited.

Authors:  Helen Coo; Hélène Ouellette-Kuntz; Jennifer E V Lloyd; Liza Kasmara; Jeanette J A Holden; M E Suzanne Lewis
Journal:  J Autism Dev Disord       Date:  2007-11-02

5.  Assessment of the prerequisite skills for cognitive behavioral therapy in children with and without autism spectrum disorders.

Authors:  Athena Lickel; William E MacLean; Audrey Blakeley-Smith; Susan Hepburn
Journal:  J Autism Dev Disord       Date:  2012-06

6.  Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders.

Authors:  Helen H L Wong; Ronald G Smith
Journal:  J Autism Dev Disord       Date:  2006-10

7.  Reduced functional connectivity between V1 and inferior frontal cortex associated with visuomotor performance in autism.

Authors:  Michele E Villalobos; Akiko Mizuno; Branelle C Dahl; Nobuko Kemmotsu; Ralph-Axel Müller
Journal:  Neuroimage       Date:  2005-04-15       Impact factor: 6.556

8.  Young adult outcome of autism spectrum disorders.

Authors:  Linda C Eaves; Helena H Ho
Journal:  J Autism Dev Disord       Date:  2007-09-01

9.  Trends in autism spectrum disorder diagnoses: 1994-2007.

Authors:  Rebecca E Rosenberg; Amy M Daniels; J Kiely Law; Paul A Law; Walter E Kaufmann
Journal:  J Autism Dev Disord       Date:  2009-03-18

10.  Linkage and linkage disequilibrium scan for autism loci in an extended pedigree from Finland.

Authors:  Helena Kilpinen; Tero Ylisaukko-oja; Karola Rehnström; Emilia Gaál; Joni A Turunen; Elli Kempas; Lennart von Wendt; Teppo Varilo; Leena Peltonen
Journal:  Hum Mol Genet       Date:  2009-05-19       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.